IDA total vs Kiribati: Cause of death, by non-communicable diseases, ages 15-59
IDA total
44.4%
in 2021
Kiribati
72.6%
in 2021
IDA total rank
34th
Kiribati rank
33rd
Cause of death, by non-communicable diseases, ages 15-59 over time
- IDA total
- Kiribati
How they compare
Kiribati currently reports 72.6% against 44.4% in IDA total, a difference of 28.2%.
That makes Kiribati's figure about 1.6 times IDA total's.
Across all 6 years both countries report, Kiribati has been ahead every year.
IDA total ranks 34th and Kiribati ranks 33rd of 47 groups.
Kiribati has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.4% | 71.5% | 38.2% | Kiribati |
| 2010s | 43.8% | 75.6% | 31.7% | Kiribati |
| 2020s | 45.3% | 74.4% | 29.0% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, IDA total or Kiribati?
- Kiribati, at 72.6% against 44.4% in IDA total as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between IDA total and Kiribati?
- 28.2%, with Kiribati ahead.
- How many years of comparable data are there for IDA total and Kiribati?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA total and Kiribati rank globally for cause of death, by non-communicable diseases, ages 15-59?
- IDA total ranks 34th and Kiribati ranks 33rd of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.